During the last session, Myriad Genetics, Inc (NASDAQ:MYGN)’s traded shares were 7.28 million, with the beta value of the company hitting 2.05. At the end of the trading day, the stock’s price was $4.03, reflecting an intraday loss of -5.62% or -$0.24. The 52-week high for the MYGN share is $29.30, that puts it down -627.05 from that peak though still a striking -5.21% loss since the share price plummeted to a 52-week low of $4.24. The company’s market capitalization is $371.45M, and the average trade volume was 1.58 million shares over the past three months.
Myriad Genetics, Inc (MYGN) received a consensus recommendation of Hold from analysts. That translates to a mean rating of 2.88. MYGN has a Sell rating from 0 analyst(s) out of 7 analysts who have looked at this stock. 5 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 2 recommend a Buy rating for it.
Myriad Genetics, Inc (NASDAQ:MYGN) trade information
Myriad Genetics, Inc (MYGN) registered a -5.62% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -5.62% in intraday trading to $4.03, hitting a weekly high. The stock’s 5-day price performance is -43.48%, and it has moved by -47.87% in 30 days. Based on these gigs, the overall price performance for the year is -79.82%.
The consensus price target of analysts on Wall Street is $12.5, which implies an increase of 67.76% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $6 and $21 respectively. As a result, MYGN is trading at a discount of -421.09% off the target high and -48.88% off the low.
While earnings are projected to return -91.01% in 2025, the next five years will return 25.05% per annum.
MYGN Dividends
Myriad Genetics, Inc is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 10.06 million shares, is of VANGUARD GROUP INC’s that is approximately 11.1089% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $246.18 million.
Also, the Mutual Funds coming in first place with the largest holdings of Myriad Genetics, Inc (MYGN) shares are iShares Trust-iShares Core S&P Small-Cap ETF and VANGUARD EXPLORER FUND . Data provided on Mar 31, 2025 indicates that iShares Trust-iShares Core S&P Small-Cap ETF owns about 5.63 shares. This amounts to just over 6.11 percent of the company’s overall shares, with a $22.68 million market value. The same data shows that the other fund manager holds slightly less at 3.29, or about 3.57% of the stock, which is worth about $13.27 million.
